EADV 2023 Insights
Playback speed
10 seconds
EADV 2023 Insights: Impact of Povorcitinib on DLQI and DLQI Subdomains in Patients with Hidradenitis Suppurativa: Results from a Randomized, Placebo-Controlled Phase 2 Study
By
EADV 2023 Insights
FEATURING
Falk Bechara
By
EADV 2023 Insights
FEATURING
Falk Bechara
120 views
October 16, 2023
Comments 0
Login to view comments.
Click here to Login